Search

everythinglearnresearchcommunity

for

Search:↓

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Skin structure complexity and variability are crucial for assessing skin toxicity in safety tests.

Diagnosing both systemic lupus and hemoglobinopathy is challenging due to overlapping symptoms.

The document concludes that proper diagnosis and treatment of follicular disorders are crucial, with specific treatments for conditions like acne, drug-induced eruptions, and rosacea.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Skin reactions from cancer treatments might predict how well the treatments work.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Topical retinoids effectively improve photodamaged skin.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Targeted anticancer therapies in children often cause skin side effects like rash and dry skin.

There is a significant need for better-validated quality of life tools in dermatology.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Paclitaxel is an effective cancer drug with side effects and potential new uses beyond cancer.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

YH0618 helped reduce skin and nail problems and fatigue in chemotherapy patients.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

Older patients with advanced kidney cancer can be managed with a drug called Sunitinib.

Researchers found a genetic link for hereditary hair loss but need more analysis to identify the exact gene.

Scientists now better understand the genetics of hypohidrotic ectodermal dysplasia, leading to more accurate diagnoses and potential new treatments.

The document says that there are treatments for hair and nail diseases.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

BMP4-related anomalies can cause a wide range of eye, brain, and hand/foot problems, and new cases show this variability.

Diabetes can cause a variety of skin disorders, some of which may signal more serious health issues.

The document explains the genetic causes and characteristics of inherited hair disorders.

A new therapy sped up wound healing and reduced scarring in diabetic rats.

Type I interferons play a key role in the development of various skin diseases.

Some skin diseases and their treatments can negatively affect male fertility.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.